logo-loader
viewTata Motors Limited

Jaguar Land Rover warns parts might run out due to China supply issues

Efforts to combat the spread of the coronavirus have resulted in factories closing all across China.

Land Rover
JLR sales have stalled in China due to Covid-19

UK car maker Jaguar Land Rover says it will start to run out of parts for its cars in two weeks due to the impact of the coronavirus on its Chinese supply chain. 

The carmaker has already used suitcases to fly in spares from China but warned that the impact will become severe unless the virus eases.

“We are safe for this week and we are safe for next week,” chief executive Sir Ralf Speth told reporters at the opening of the National Automotive Innovation Centre in Coventry where it launched a new city transport concept – Project Vector.

Jaguar Land Rover is the UK’s larger car manufacturer, producing 400,000 vehicles a year from factories at Castle Bromwich, Solihull and Halewood.

Efforts to combat the spread of the coronavirus have resulted in factories closing all across China.

Apple warned earlier this week that it would miss its sales targets for this quarter due to the supply issues and the impact on iPhone sales because of the clampdown on movement within the country.

Speth added that JLR sales in China had also been badly affected though it expects its own factory there to re-open next week.

Coronavirus or Covid-19 has resulted in more than 1,800 deaths so far with over 70,000 people infected.

Jaguar Land Rover is owned by India’s Tata Motors (NYSE:TTM).

Quick facts: Tata Motors Limited

Price: 4.6 USD

NYSE:TTM
Market: NYSE
Market Cap: $3.31 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CytoDyn's therapy used to treat New York coronavirus...

CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive the biotech shared positive test results today from seven coronavirus (COVID-19) patients who were treated with the company’s drug leronlimab at a leading medical center in the New York City area. Pourhassan, together diagnostics...

1 day, 5 hours ago

2 min read